SANUWAVE Health Files Restated 10-K, Reports Strong 2025 Revenue Growth & Net Income, Alleviates Going Concern Doubt
SNWV is trading near its 52-week low of $18.61 (0.6% below the low) on elevated volume (2.8× avg).
Summary
SANUWAVE Health, Inc. filed its annual 10-K, including a restatement of prior financials due to sales tax and warranty accounting errors. Despite this, the company reported a 35% revenue increase to $44.1 million and a net income of $11.8 million for 2025, successfully alleviating prior going concern doubts through debt refinancing and improved operations.
Key Events · Corporate Governance and Compliance · SNWV
-
Financial Restatement of Prior Periods
The company restated its 2024 annual and 2024-2025 quarterly financial statements to correct errors related to sales tax liabilities and overstated revenue from extended warranties.
-
Significant 2025 Financial Turnaround
Reported a 35% increase in total revenues to $44.1 million for 2025, and a net income of $11.8 million, a substantial improvement from a $33.1 million net loss in 2024.
-
Alleviation of Going Concern Doubt
Management concluded that the substantial doubt about the company's ability to continue as a going concern was alleviated as of Q3 2025, attributed to debt refinancing and improved operating performance.
-
Debt Refinancing Completed
In September 2025, the company secured a new $23.0 million term loan and a $5.0 million revolving credit facility, retiring prior senior secured debt and extending maturity dates.
Analysis · SNWV · Industrial Applications And Services
SANUWAVE Health, Inc. filed its annual 10-K, which includes a restatement of previously issued financial statements for 2024 and quarterly periods in 2024 and 2025. The restatement addresses sales tax accounting errors and overstated revenue related to extended warranties. Despite these prior accounting issues, the company reported a significant financial turnaround in 2025, with revenues increasing by 35% to $44.1 million and a shift from a $33.1 million net loss in 2024 to an $11.8 million net income in 2025. This positive performance, coupled with a successful debt refinancing in Q3 2025, has led management to conclude that the substantial doubt about the company's ability to continue as a going concern has been alleviated. However, the company continues to report material weaknesses in its internal control over financial reporting, with remediation efforts ongoing. This filing provides critical clarity on past financial reporting issues and a strong signal of operational improvement and financial stability.
At the time of this filing, SNWV was trading at $18.50 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $161.7M. The 52-week trading range was $18.61 to $46.59. This filing was assessed with positive market sentiment and an importance score of 9 out of 10.